| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.21 | 0.009 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |